Related Experiment Videos

Molecular pathology of the amyloid A4 precursor of Alzheimer's disease

T Dyrks1, G König, C Hilbich

  • 1Center for Molecular Biology, University of Heidelberg (ZMBH), F.R., Germany.

Progress in Clinical and Biological Research
|January 1, 1989
PubMed

Insights

Alzheimer's disease amyloid A4 protein precursor is a membrane protein. Its C-terminal region aggregates, suggesting a link to amyloid A4 formation and potential roles for membrane damage in disease progression.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alzheimer's disease is characterized by amyloid-beta plaques.
  • The amyloid A4 protein is a key component of these plaques.
  • Understanding the precursor protein is crucial for Alzheimer's research.

Purpose of the Study:

  • To characterize the structure and properties of the Alzheimer's disease-specific amyloid A4 protein precursor.
  • To investigate the aggregation tendency of the precursor's C-terminal domain.
  • To explore potential mechanisms for amyloid A4 subunit release.

Main Methods:

  • Analysis of integral membrane protein structure.
  • Identification of protein domains and their localization (cytoplasmic vs. extracellular).
  • Assessment of protein aggregation propensity.

Main Results:

  • The amyloid A4 precursor is a single-pass glycosylated membrane protein.
  • The C-terminal domain (47 residues) is cytoplasmic.
  • The C-terminal 100 residues, including the amyloid A4 region, exhibit high aggregation tendency.

Conclusions:

  • A precursor-product relationship exists between the precursor protein and amyloid A4.
  • Proteolytic cleavage and membrane damage are potential triggers for amyloid A4 subunit release.
  • Aggregation propensity highlights the C-terminal domain's significance in Alzheimer's pathology.

Related Concept Videos